- Home
- FN vs QGEN Comparison
FN vs QGEN Comparison
Compare FN & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FN
- QGEN
- Stock Information
- Founded
- FN 1999
- QGEN 1986
- Country
- FN Cayman Islands
- QGEN Netherlands
- Employees
- FN N/A
- QGEN N/A
- Industry
- FN Telecommunications Equipment
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FN Utilities
- QGEN Health Care
- Exchange
- FN Nasdaq
- QGEN Nasdaq
- Market Cap
- FN 12.1B
- QGEN 10.3B
- IPO Year
- FN 2010
- QGEN 1996
- Fundamental
- Price
- FN $377.35
- QGEN $45.84
- Analyst Decision
- FN Buy
- QGEN Buy
- Analyst Count
- FN 7
- QGEN 8
- Target Price
- FN $306.33
- QGEN $51.01
- AVG Volume (30 Days)
- FN 811.7K
- QGEN 1.3M
- Earning Date
- FN 11-03-2025
- QGEN 11-05-2025
- Dividend Yield
- FN N/A
- QGEN 3.32%
- EPS Growth
- FN 13.21
- QGEN 405.09
- EPS
- FN 9.17
- QGEN 1.69
- Revenue
- FN $3,419,327,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- FN $20.32
- QGEN $7.22
- Revenue Next Year
- FN $15.31
- QGEN $5.66
- P/E Ratio
- FN $39.26
- QGEN $26.93
- Revenue Growth
- FN 18.60
- QGEN 5.15
- 52 Week Low
- FN $148.55
- QGEN $37.63
- 52 Week High
- FN $380.01
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- FN 65.33
- QGEN 39.00
- Support Level
- FN $348.01
- QGEN $45.18
- Resistance Level
- FN $368.25
- QGEN $46.18
- Average True Range (ATR)
- FN 14.81
- QGEN 0.67
- MACD
- FN 0.66
- QGEN -0.13
- Stochastic Oscillator
- FN 97.93
- QGEN 23.49
About FN Fabrinet
Fabrinet provides advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).